Background: Mycoplasma pneumoniae (MP) is the primary causative agent of community-acquired pneumonia, which has increasingly become resistant to macrolides, complicating treatment regimens, especially with the co-infection factor. Its worldwide prevalence has fluctuated due to the influence of the COVID-19 pandemic. The study investigated co-infection patterns in children diagnosed with Mycoplasma pneumoniae pneumonia (MPP). Methods: From June 2022 to December 2023, we retrospectively analyzed the clinical data for hospitalized children with Mycoplasma pneumoniae pneumonia in Wuhan, China. We collected data on age, sex, clinical information, and pathogenic results. We also collected sputum or bronchoalveolar lavage fluid (BALF) samples to test respiratory pathogens and macrolide resistance using targeted microbial next-generation sequencing (tNGS). We analyzed the data using SPSS. Results: The study involved 417 patients diagnosed with MPP, of whom 86.33% had co-infections. Co-infections were notably linked to lobar pneumonia, prominent imaging shadows and higher macrolide resistance rate. Key bacterial pathogens were Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, rhinoviruses, and human adenoviruses (HADV). In MPP cases, Candida albicans was the fungal pathogen related to co-infections. The co-infection with HADV and human bocavirus 1 (HBoV1) correlated with prolonged fever, whereas Bordetella pertussis was linked to prolonged cough. In contrast, Candida albicans exhibited a weaker association with diffuse large-area infiltration on chest imaging, and its co-infection was less likely to result in severe disease. Conclusion: These results offer valuable insight into Mycoplasma pneumoniae pneumonia in children, highlighting the impact of co-infections on the disease’s clinical outcomes.
References
[1]
Chiu, C., Chen, C., Wong, K., Tsai, M., Chiu, C. and Huang, Y. (2015) Impact of Bacterial and Viral Coinfection on Mycoplasmal Pneumonia in Childhood Community-Acquired Pneumonia. JournalofMicrobiology, ImmunologyandInfection, 48, 51-56. https://doi.org/10.1016/j.jmii.2013.06.006
[2]
Mao, J., Niu, Z., Liu, M., et al. (2024) The Epidemiological Characteristics of Mycoplasma pneumoniae Infection and Coinfection among Children in Central China from 2018 to 2023. https://doi.org/10.21203/rs.3.rs-4617945/v1
[3]
Lin, X., Xu, E., Zhang, T., Zhu, Q., Liu, Y. and Tian, Q. (2025) Cytokine-Based Nomogram for Discriminating Viral Pneumonia from Mycoplasma pneumoniae Pneumonia in Children. Diagnostic Microbiology and Infectious Disease, 111, Article ID: 116611. https://doi.org/10.1016/j.diagmicrobio.2024.116611
[4]
Skevaki, C.L., Tsialta, P., Trochoutsou, A.I., Logotheti, I., Makrinioti, H., Taka, S., et al. (2015) Associations between Viral and Bacterial Potential Pathogens in the Nasopharynx of Children with and without Respiratory Symptoms. Pediatric Infectious DiseaseJournal, 34, 1296-1301. https://doi.org/10.1097/inf.0000000000000872
[5]
Tomsa, N., Melit, L.E., Popescu, T. and Marginean, C.O. (2024) Mycoplasma pneumoniae Pneumonia—Challenges Related to Diagnosis and Treatment in Children. RomanianJournalofInfectiousDiseases, 27, 46-50. https://doi.org/10.37897/rjid.2024.1.12
[6]
Shinozaki, T., Sasahara, K., Iwami, E., Kuroda, A., Matsuzaki, T., Nakajima, T., et al. (2018) A Case of Influenza B and Mycoplasma pneumoniae Coinfection in an Adult. CaseReportsinInfectiousDiseases, 2018, Article ID: 3529358. https://doi.org/10.1155/2018/3529358
[7]
Zhang, X., Chen, Z., Gu, W., Ji, W., Wang, Y., Hao, C., et al. (2018) Viral and Bacterial Co-Infection in Hospitalised Children with Refractory Mycoplasma pneumoniae Pneumonia. EpidemiologyandInfection, 146, 1384-1388. https://doi.org/10.1017/s0950268818000778
[8]
Zhou, Y., Wang, J., Chen, W., Shen, N., Tao, Y., Zhao, R., et al. (2020) Impact of Viral Coinfection and Macrolide-Resistant Mycoplasma Infection in Children with Refractory Mycoplasma pneumoniae Pneumonia. BMCInfectiousDiseases, 20, Article No. 633. https://doi.org/10.1186/s12879-020-05356-1
[9]
Shin, S., Koo, S., Yang, Y. and Lim, H. (2023) Characteristics of the Mycoplasma pneumoniae Epidemic from 2019 to 2020 in Korea: Macrolide Resistance and Co-Infection Trends. Antibiotics, 12, Article 1623. https://doi.org/10.3390/antibiotics12111623
[10]
Wu, X., Chen, R., Mo, D., Wang, Y., Xia, Y. and He, M. (2024) Analysis of Mycoplasma pneumoniae Pneumonia and Viral Coinfection in Southern Guangzhou after the COVID-19 Pandemic. JournalofThoracicDisease, 16, 6789-6798. https://doi.org/10.21037/jtd-24-729
[11]
Han, Y., Wang, D., Wang, Q., Liu, Y., Yan, M., Ren, F., et al. (2025) Seasonal Shifts in Respiratory Pathogen Co-Infections and the Associated Differential Induction of Cytokines in Children. Cytokine, 186, Article ID: 156847. https://doi.org/10.1016/j.cyto.2024.156847
[12]
Dekyi,, Xiao, Y., Wang, X., Feng, S., Wang, Y., Liao, L., et al. (2024) Predominance of A2063G Mutant Strains in the Mycoplasma pneumoniae Epidemic in Children: A Clinical and Epidemiological Study in 2023 in Wuhan, China. International Journal of InfectiousDiseases, 145, Article ID: 107074. https://doi.org/10.1016/j.ijid.2024.107074
[13]
Chen, Q., Lin, L., Zhang, N. and Yang, Y. (2024) Adenovirus and Mycoplasma pneumoniae Co-Infection as a Risk Factor for Severe Community-Acquired Pneumonia in Children. FrontiersinPediatrics, 12, Article 1337786. https://doi.org/10.3389/fped.2024.1337786
[14]
Choo, S., Lee, Y.Y. and Lee, E. (2022) Clinical Significance of Respiratory Virus Coinfection in Children with Mycoplasma pneumoniae Pneumonia. BMC Pulmonary Medicine, 22, Article No. 212. https://doi.org/10.1186/s12890-022-02005-y
[15]
Sung, M., Roh, E.J., Lee, E.S., Lee, J.Y., Kim, H., Ahn, Y., et al. (2022) Assessment of Variables Associated with Prolonged Admission Duration in Children with Mycoplasma pneumoniae Pneumonia. TheClinicalRespiratoryJournal, 16, 756-767. https://doi.org/10.1111/crj.13549
[16]
Xu, Y., Li, S., Liu, J., Zhou, J., Jin, F., Chen, X., et al. (2020) Impact of Epstein-Barr Virus Coinfection in Mycoplasma pneumoniae Pneumonia. Medicine, 99, e19792. https://doi.org/10.1097/md.0000000000019792
[17]
Tran Quang, K., Tran Do, H., Pham Hung, V., Nguyen Vu, T., Tran Xuan, B., Larsson, M., et al. (2021) Study on the Co‐Infection of Children with Severe Community-Acquired Pneumonia. PediatricsInternational, 64, e14853. https://doi.org/10.1111/ped.14853
[18]
Gao, J., Xu, L., Xu, B., Xie, Z. and Shen, K. (2020) Human Adenovirus Coinfection Aggravates the Severity of Mycoplasma pneumoniae Pneumonia in Children. BMCInfectiousDiseases, 20, Article No. 420. https://doi.org/10.1186/s12879-020-05152-x
[19]
Sung, M., Choi, H.J., Lee, M.H., et al. (2022) Regional and Annual Patterns in Respiratory Virus Co-Infection Etiologies and Antibiotic Prescriptions for Pediatric Mycoplasma pneumoniae Pneumonia. European Review for Medical and Pharmacological Sciences, 26, 5844-5856. https://doi.org/10.26355/eurrev_202208_29524
[20]
del Rosal, T., Bote-Gascón, P., Falces-Romero, I., Sainz, T., Baquero-Artigao, F., Rodríguez-Molino, P., et al. (2024) Multiplex PCR and Antibiotic Use in Children with Community-Acquired Pneumonia. Children, 11, Article 245. https://doi.org/10.3390/children11020245
[21]
Ly, V.K., Pham, V.H., Ly, X.V. and Pham, P.M. (2024) Bacterial and Viral Co-Infections in Community-Acquired Pneumonia in Adults: A Prospective Study of Multiple Hospital Centers. MedPharmRes, 8, 153-161. https://doi.org/10.32895/ump.mpr.8.3.17
[22]
Lai, C.C., Hsueh, C., Hsu, C., Tsai, Y. and Hsueh, P. (2024) Disease Burden and Macrolide Resistance of Mycoplasma pneumoniae Infection in Adults in the Asia-Pacific Region. InternationalJournalofAntimicrobialAgents, 64, Article ID: 107205. https://doi.org/10.1016/j.ijantimicag.2024.107205
[23]
Pereyre, S., Goret, J. and Bébéar, C. (2016) Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment. FrontiersinMicrobiology, 7, Article 974. https://doi.org/10.3389/fmicb.2016.00974
[24]
Guo, Q., Li, L., Wang, C., Huang, Y., Ma, F., Cong, S., et al. (2022) Comprehensive Virome Analysis of the Viral Spectrum in Paediatric Patients Diagnosed with Mycoplasma pneumoniae Pneumonia. VirologyJournal, 19, Article No. 181. https://doi.org/10.1186/s12985-022-01914-y
[25]
Chironna, M., Sallustio, A., Esposito, S., Perulli, M., Chinellato, I., Di Bari, C., et al. (2011) Emergence of Macrolide-Resistant Strains during an Outbreak of Mycoplasma pneumoniae Infections in Children. Journal of Antimicrobial Chemotherapy, 66, 734-737. https://doi.org/10.1093/jac/dkr003
